Patients Coming Off Weight-Loss Injections Regain Weight Far More Rapidly Than Dieters

A recent study suggests that individuals who stop using popular slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass much more quickly than those who halt conventional lifestyle programs.

Published data in a leading medical journal shows that while obese people frequently drop substantial amounts of their body weight while on the medication, the weight is regained at an average rate of nearly a kilo each month upon discontinuation.

"Individuals purchasing these drugs must be aware of the danger of quick weight regain when the medication concludes," stated lead investigator Dr. Susan Jebb.

This pace of recovery implies a return to original mass in about a year and a half.

Weighing Therapies

The research, which examined 37 of trials involving thousands of patients, contrasted the results of the injectable medications with conventional dieting.

Scientists note that individuals who shed pounds through diet and exercise usually experience a more gradual weight regain—approximately 100 grams monthly—once they finish.

Understanding the Rapid Regain

Doctors suggest the mode of action of the injections is key to understanding the heightened weight return.

These medications copy a natural hormone called glucagon-like peptide-1, which moderates appetite.

"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the system to generate a reduced amount of its endogenous GLP-1, and may also reduce responsiveness to its effects," explained Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this GLP-1 'fix' results in hunger is uncontrolled, making binge eating a significant risk."

A Chronic Issue?

Medical guidelines advise the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals say that, considering the likelihood of weight regain, the therapy should be considered long-term.

This perspective is reinforced by pharmaceutical companies, who say that the results "emphasize the chronic nature of obesity," comparing it to managing conditions like high blood pressure.

Patient Experiences

Individuals who have stopped the medication explain a sudden return of hunger.

"It was like a trigger flipping and you become extremely hungry," described an individual.

This difficulty is compounded if individuals have not developed permanent lifestyle or habit modifications during treatment.

Growing Interest

Figures suggest that a significant number of adults in the UK have tried these injections in the past year, with desire remaining high.

• Use is higher among women compared to men.
• The middle-aged age group shows the highest usage rates.
• Many obtain the drugs through private healthcare rather than the NHS.

In conclusion, researchers emphasize that while the jabs are powerful agents for weight loss, they are not a permanent fix and lasting health benefits hinges on ongoing behavioural support.